Clinical Study of Olanzapine combined with Danggui Chengqi mixture in the treatment of schizophrenia
- Conditions
- Schizophrenia
- Registration Number
- ITMCTR2000003141
- Lead Sponsor
- Mental health center affiliated to Medical College of Shanghai Jiaotong University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Aged 18-65 years old male and female, primary education level or above;
2. Patients who meet the international classification of diseases (ICD) diagnostic criteria for schizophrenia; Those patients who are suffering from epilepsy with phlegm, fire, disturbance of spirit and stagnation of Qi and blood in accordance with the industry standard of the State Administration of traditional Chinese Medicine;
3. Positive and negative symptom scale: PANSS score >=6O;
4. Patients or their families have sufficient cultural, social and educational background to understand the content of informed consent and research and sign informed consent.
1. Patients in other clinical studies;
2. Patients with diagnosis other than schizophrenia in accordance with ICD-10;
3. With serious physical disease, brain organic disease, head trauma, etc.;
4. Patients with a significant risk of suicide or endangering themselves or others;
5. Pregnant and lactating women.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PANSS;TESS;CGI;Symptom checklist of traditional Chinese medicine;
- Secondary Outcome Measures
Name Time Method PSP;RBANS;MARS;SF-36;IL-6;Olanzapine concentration;5-HT;EKG;EEG;DA;IL-1beta;